FDA Inspection
Saving SightSaving Sight – FDA Inspection, Feb 19, 2014
Record Details
This FDA Inspection record concerns Saving Sight, with an inspection on February 19, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Saving Sight
- Inspection Date
- February 19, 2014
- Product Type
- Biologics
View Company Profile
ID · c8b244a1-2d21-4810-ab06-e0db384b878b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 865613
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.180(a)Design adequate to bar spread of CD"s
- 21 CFR 1271.270(a)Accurate, indelible, legible
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Saving Sight
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2026 | Not classified | Kansas City District Office | |
| September 19, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 21, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 18, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 5, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Saving Sight
- FDA Inspection 1308808 - 2026-02-25
- FDA Inspection 1067121 - 2018-09-19
- FDA Inspection 971525 - 2016-04-21
- FDA Inspection 776191 - 2012-04-18
- FDA Inspection 657417 - 2010-04-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.